NCT05806385 2025-09-09
LOGIC
Texas Tech University Health Sciences Center
Phase 1/2 Not yet recruiting
Clinical Trials
19 trialsNCT03325101 2025-06-12
Dendritic Cell Therapy With Pembrolizumab for Metastatic or Unresectable Melanoma
Mayo Clinic
Phase 1/2 Terminated
NCT03035331 2025-05-16
Dendritic Cell Therapy, Cryosurgery, and Pembrolizumab in Treating Patients With Non-Hodgkin Lymphoma
Mayo Clinic
Phase 1/2 Completed
NCT03183206 2020-07-13
Safety and Efficiency of γδ T Cell Against Breast Cancer
Fuda Cancer Hospital, Guangzhou
Phase 1/2 Completed
NCT03183219 2020-07-13
Safety and Efficiency of γδ T Cell Against Liver Cancer
Fuda Cancer Hospital, Guangzhou
Phase 1/2 Completed
NCT03183232 2020-07-13
Safety and Efficiency of γδ T Cell Against Lung Cancer
Fuda Cancer Hospital, Guangzhou
Phase 1/2 Completed
NCT02018419 2020-01-22
MBC
Mirror Biologics, Inc.
Phase 1/2 Withdrawn
NCT01853618 2019-12-10
Tremelimumab With Chemoembolization or Ablation for Liver Cancer
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed
NCT02843581 2019-09-12
Combination of Cryosurgery and NK Immunotherapy for Advanced Esophageal Cancer
Fuda Cancer Hospital, Guangzhou
Phase 1/2 Completed
NCT02843802 2019-09-12
Combination of Cryosurgery and NK Immunotherapy for Advanced Liver Cancer
Fuda Cancer Hospital, Guangzhou
Phase 1/2 Completed
NCT02843815 2019-09-12
Combination of Cryosurgery and NK Immunotherapy for Advanced Non-Small Cell Lung Cancer
Fuda Cancer Hospital, Guangzhou
Phase 1/2 Completed
NCT02844335 2019-09-12
Combination of Cryosurgery and NK Immunotherapy for Advanced Breast Cancer
Fuda Cancer Hospital, Guangzhou
Phase 1/2 Completed
NCT02849015 2019-09-12
Combination of Cryosurgery and NK Immunotherapy for Tumors in Transplanted Liver
Fuda Cancer Hospital, Guangzhou
Phase 1/2 Completed
NCT02849314 2019-09-12
Combination of Cryosurgey and NK Immunotherapy for Recurrent Laryngeal Cancer
Fuda Cancer Hospital, Guangzhou
Phase 1/2 Completed
NCT02849340 2019-09-12
Combination of Cryosurgey and NK Immunotherapy for Recurrent Cervical Cancer
Fuda Cancer Hospital, Guangzhou
Phase 1/2 Completed
NCT02849353 2019-09-12
Combination of Cryosurgey and NK Immunotherapy for Recurrent Ovarian Cancer
Fuda Cancer Hospital, Guangzhou
Phase 1/2 Completed
NCT02849366 2019-09-12
Combination of Cryosurgery and NK Immunotherapy for Recurrent Sarcoma
Fuda Cancer Hospital, Guangzhou
Phase 1/2 Completed
NCT02849379 2019-09-12
Combination of Cryosurgey and NK Immunotherapy for Recurrent Tongue Cancer
Fuda Cancer Hospital, Guangzhou
Phase 1/2 Completed
NCT02545556 2016-08-29
Liver Cancer HepaSphere Combined With Cryosurgery
Fuda Cancer Hospital, Guangzhou
Phase 1/2 Completed